AstraZeneca Sponsors ACC Patient Navigator Program


Michele Meixell

By Jim Blasetto, MD, cardiologist and Vice President, US Strategic Development, AstraZeneca

AstraZeneca today announced a $10 million contribution to the American College of Cardiology (ACC) Patient Navigator program.

By the end of 2015, the ACC will enroll 35 hospitals across the country to support patients through the challenges of transitioning from hospital to home following their heart attack.

The ACC Patient Navigator program will provide personalized support to patients with acute coronary syndrome (ACS) based on their specific needs, which is vital because cardiovascular disease impacts every patient differently. The program will support patients with ACS as they face physical, emotional and other issues after having a heart attack. According to the ACC, one of the goals is to make ACS patients’ hospitalization less stressful and the recovery period more supportive.

AstraZeneca supports the ACC as they build a patient support program to enhance patient health and work to reduce unnecessary hospital readmissions.

The sponsorship of the ACC Patient Navigator Program aligns with AstraZeneca’s desire to put patients at the core of everything we do and a commitment to finding new ways to support patients and patients’ health.

While ACC advises that it is too early to provide details about the specific resources that will be made available to patients, Patient Navigators teams will assist patients as they face the challenges of the discharge and post-discharge environments. Navigators may work with patients on such items as supporting all medication adherence, providing practical tips on community resources and disseminating nutrition and exercise counseling.